Cargando…
Altered Matrix Metalloproteinases Expression in Placenta from Patients with Gestational Diabetes Mellitus
Autores principales: | Ding, Rong, Liu, Xi-Mei, Xiang, Yu-Qian, Zhang, Yong, Zhang, Jun-Yu, Guo, Fei, Liu, Zhi-Wei, Fan, Jian-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956783/ https://www.ncbi.nlm.nih.gov/pubmed/29722349 http://dx.doi.org/10.4103/0366-6999.231530 |
Ejemplares similares
-
Ultrastructure of Placenta of Gravidas with Gestational Diabetes Mellitus
por: Meng, Qian, et al.
Publicado: (2015) -
Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021) -
Upregulation of IL-15 in the placenta alters trophoblasts behavior contributing to gestational diabetes mellitus
por: Li, Jiaqi, et al.
Publicado: (2021) -
Correction to: Upregulation of IL-15 in the placenta alters trophoblasts behavior contributing to gestational diabetes mellitus
por: Li, Jiaqi, et al.
Publicado: (2021) -
Reply to Comments on ‘A functional polymorphism rs10830963 in melatonin receptor 1B associated with the risk of gestational diabetes mellitus’
por: Huang, Bo, et al.
Publicado: (2020)